Header Logo

Connection

LEILA SAHNI to Adolescent

Back to Details
This is a "connection" page, showing publications LEILA SAHNI has written about Adolescent.
LEILA SAHNI
Connection Strength
0.568
Adolescent
  1. Factors Associated With COVID-19 Non-vaccination in Adolescents Hospitalized Without COVID-19. J Pediatric Infect Dis Soc. 2023 Feb 09; 12(1):29-35.
    View in: PubMed
    Score: 0.055
  2. Arboviral Surveillance among Pediatric Patients with Acute Febrile Illness in Houston, Texas. Am J Trop Med Hyg. 2018 08; 99(2):413-416.
    View in: PubMed
    Score: 0.040
  3. Antiviral Use Among Children Hospitalized With Laboratory-Confirmed Influenza Illness: A Prospective, Multicenter Surveillance Study. Clin Infect Dis. 2025 Oct 06; 81(3):623-633.
    View in: PubMed
    Score: 0.017
  4. Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024. JAMA Netw Open. 2025 Sep 02; 8(9):e2531499.
    View in: PubMed
    Score: 0.016
  5. Human Metapneumovirus and Respiratory Syncytial Virus in Children: A Comparative Analysis. Pediatrics. 2025 Sep 01; 156(3).
    View in: PubMed
    Score: 0.016
  6. Acute Gastroenteritis Among Household Contacts of Children with Severe Norovirus Gastroenteritis, United States, 2011-2016. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.016
  7. Adenovirus Species in U.S. Children With Acute Respiratory Illness, 2016-2019. J Pediatric Infect Dis Soc. 2025 Jun 16; 14(6).
    View in: PubMed
    Score: 0.016
  8. Prevalence of human adenovirus in children with acute gastroenteritis in the New Vaccine Surveillance Network (NVSN) from 2016 to 2019. J Clin Virol. 2025 Aug; 179:105822.
    View in: PubMed
    Score: 0.016
  9. Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020. Influenza Other Respir Viruses. 2025 Jun; 19(6):e70124.
    View in: PubMed
    Score: 0.016
  10. Epidemiology and genotypic diversity of rhinovirus in school-age children with acute respiratory illnesses seeking medical care. J Clin Virol. 2025 Aug; 179:105806.
    View in: PubMed
    Score: 0.016
  11. Enterovirus D68-Associated Respiratory Illness in Children. JAMA Netw Open. 2025 05 01; 8(5):e259131.
    View in: PubMed
    Score: 0.016
  12. The Epidemiology and Burden of Human Parainfluenza Virus Hospitalizations in US Children. J Pediatric Infect Dis Soc. 2025 Apr 08; 14(4).
    View in: PubMed
    Score: 0.016
  13. Interim Estimates of 2024-2025 Seasonal Influenza Vaccine Effectiveness - Four Vaccine Effectiveness Networks, United States, October 2024-February 2025. MMWR Morb Mortal Wkly Rep. 2025 Feb 27; 74(6):83-90.
    View in: PubMed
    Score: 0.016
  14. Pediatric Clinical Influenza Disease by Type and Subtype 2015-2020: A Multicenter, Prospective Study. J Pediatric Infect Dis Soc. 2025 Jan 20; 14(1).
    View in: PubMed
    Score: 0.016
  15. Estimated Vaccine Effectiveness for Pediatric Patients With Severe Influenza, 2015-2020. JAMA Netw Open. 2024 12 02; 7(12):e2452512.
    View in: PubMed
    Score: 0.016
  16. Underutilization of Influenza Antiviral Treatment Among Children and Adolescents at Higher Risk for Influenza-Associated Complications - United States, 2023-2024. MMWR Morb Mortal Wkly Rep. 2024 Nov 14; 73(45):1022-1029.
    View in: PubMed
    Score: 0.016
  17. Prevalence of SARS-CoV-2 in Children Identified by Preprocedural Testing at 5 US Children's Hospital Systems. Pediatr Infect Dis J. 2025 Jan 01; 44(1):47-53.
    View in: PubMed
    Score: 0.015
  18. Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023. MMWR Morb Mortal Wkly Rep. 2024 Apr 18; 73(15):330-338.
    View in: PubMed
    Score: 0.015
  19. Accuracy of Influenza ICD-10 Diagnosis Codes in Identifying Influenza Illness in Children. JAMA Netw Open. 2024 04 01; 7(4):e248255.
    View in: PubMed
    Score: 0.015
  20. Notes from the Field: Reemergence of Mycoplasma pneumoniae Infections in Children and Adolescents After the COVID-19 Pandemic, United States, 2018-2024. MMWR Morb Mortal Wkly Rep. 2024 Feb 22; 73(7):149-151.
    View in: PubMed
    Score: 0.015
  21. Circulation of Rhinoviruses and/or Enteroviruses in Pediatric Patients With Acute Respiratory Illness Before and During the COVID-19 Pandemic in the US. JAMA Netw Open. 2023 02 01; 6(2):e2254909.
    View in: PubMed
    Score: 0.014
  22. Clinical Presentation and Severity of Adenovirus Detection Alone vs Adenovirus Co-detection With Other Respiratory Viruses in US Children With Acute Respiratory Illness from 2016 to 2018. J Pediatric Infect Dis Soc. 2022 Oct 25; 11(10):430-439.
    View in: PubMed
    Score: 0.014
  23. Respiratory Virus Surveillance Among Children with Acute Respiratory Illnesses - New Vaccine Surveillance Network, United States, 2016-2021. MMWR Morb Mortal Wkly Rep. 2022 Oct 07; 71(40):1253-1259.
    View in: PubMed
    Score: 0.013
  24. Investigating Health Disparities Associated With Multisystem Inflammatory Syndrome in Children After SARS-CoV-2 Infection. Pediatr Infect Dis J. 2022 11 01; 41(11):891-898.
    View in: PubMed
    Score: 0.013
  25. Vaccine Effectiveness Against Influenza Hospitalization and Emergency Department Visits in 2 A(H3N2) Dominant Influenza Seasons Among Children <18 Years Old-New Vaccine Surveillance Network 2016-2017 and 2017-2018. J Infect Dis. 2022 08 12; 226(1):91-96.
    View in: PubMed
    Score: 0.013
  26. BNT162b2 Protection against the Omicron Variant in Children and Adolescents. N Engl J Med. 2022 05 19; 386(20):1899-1909.
    View in: PubMed
    Score: 0.013
  27. Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 14; 71(2):52-58.
    View in: PubMed
    Score: 0.013
  28. Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022 02 24; 386(8):713-723.
    View in: PubMed
    Score: 0.013
  29. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-November 2018-2020. MMWR Morb Mortal Wkly Rep. 2021 Nov 26; 70(47):1623-1628.
    View in: PubMed
    Score: 0.013
  30. Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021. MMWR Morb Mortal Wkly Rep. 2021 Oct 22; 70(42):1483-1488.
    View in: PubMed
    Score: 0.013
  31. Acute Respiratory Illnesses in Children in the SARS-CoV-2 Pandemic: Prospective Multicenter Study. Pediatrics. 2021 08; 148(2).
    View in: PubMed
    Score: 0.012
  32. Severe Acute Respiratory Syndrome Coronavirus 2 Infections in Children: Multicenter Surveillance, United States, January-March 2020. J Pediatric Infect Dis Soc. 2020 Nov 10; 9(5):609-612.
    View in: PubMed
    Score: 0.012
  33. Vaccine Effectiveness Against Pediatric Influenza Hospitalizations and Emergency Visits. Pediatrics. 2020 11; 146(5).
    View in: PubMed
    Score: 0.012
  34. Enterovirus D68-Associated Acute Respiratory Illness - New Vaccine Surveillance Network, United States, July-October, 2017 and 2018. MMWR Morb Mortal Wkly Rep. 2019 Mar 29; 68(12):277-280.
    View in: PubMed
    Score: 0.011
  35. Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine. 2016 Mar 08; 34(11):1335-42.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.